Top Story

Januvia may prevent heart disease in HIV patients

May 21, 2015

The antidiabetic drug Januvia demonstrated beneficial systemic and adipose anti-inflammatory effects in HIV-infected adults with impaired glucose tolerance, according to research published in the Journal of Clinical Endocrinology and Metabolism.

“The goal has been to identify treatments that not only address problems with blood sugar and lipids, but also can lower inflammation, which can play a substantial role in heart disease and stroke,” Kevin E. Yarasheski, PhD, professor of medicine at Washington University School of Medicine, said in a press release. “With [Januvia (sitagliptin, Merck)], sugar levels fell, and several markers of immune activation and inflammation were reduced, indicating the drug may provide long-term benefits for these patients’ hearts, bones and livers.”

In the Journals

Diabetes linked to increased CVD mortality risk among Chinese adults

April 29, 2015
An increased risk for death among Chinese adults, especially from cardiovascular disease, is linked to diabetes, according to recent study findings published in…
April Armstrong In the Journals

Diabetic patients with psoriasis may have higher risk of microvascular, macrovascular complications

April 28, 2015
Diabetic patients with psoriasis generally had an increased risk microvascular and macrovascular complications compared with diabetic patients without psoriasis;…
In the Journals

Type 1 diabetes increases post-CABG mortality risk

April 22, 2015
Patients with type 1 diabetes appear to have twice the risk for death after undergoing CABG than patients without type 1 diabetes, according to recent findings.Type 2…
CME
Examining Diverse Patient Populations and Their Response to Therapy

Examining Diverse Patient Populations and Their Response to Therapy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Antiplatelet Therapy in ACS and PCI

Antiplatelet Therapy in ACS and PCI

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
thumbnail for video 3857626096001 Meeting News CoverageVideo

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed primarily at diabetes or…
Keith C. Ferdinand Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke…
Stijn Peeters Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to…
Matthew J. Price, MD In the Journals

Clopidogrel response impaired among patients with diabetes, CAD

September 4, 2014
Patients with diabetes and CAD experienced an impaired response to platelet P2Y12 receptor antagonist clopidogrel compared with those without…
In the Journals

Insulin use, dialysis predicted poor wound healing after endovascular therapy

August 28, 2014
Patients undergoing endovascular therapy for critical limb ischemia were significantly more likely to have non-healing wounds if they used insulin…
James F. McKinsey In the JournalsPerspective

DEFINITIVE LE published: Directional atherectomy effective regardless of diabetes status

August 27, 2014
Patients with or without diabetes who underwent directional atherectomy for peripheral artery disease experienced similar rates of primary patency at…

Nutrition education lacking in medical training

August 26, 2014
A group of physicians are questioning how well doctors can provide nutrition information and counseling to patients, particularly those with CVD…
More Headlines »
morganatic-roan